Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 30;15(8):e44417.
doi: 10.7759/cureus.44417. eCollection 2023 Aug.

Exploring Cardiovascular Manifestations in Vasculitides: An In-Depth Review

Affiliations
Review

Exploring Cardiovascular Manifestations in Vasculitides: An In-Depth Review

Vaibhav Vats et al. Cureus. .

Abstract

Systemic vasculitides encompass a cluster of autoimmune diseases that affect blood vessels, and are characterized by immune-mediated injury to either small- or large-sized blood vessels. Individuals afflicted with systemic vasculitides experience notable morbidity and mortality attributable to cardiovascular manifestations. Noteworthy among these are ischemic heart disease, venous thromboembolism, aortic involvement, valvular irregularities, myocarditis, and pericarditis. This narrative review investigated and evaluated the prevalent cardiovascular disturbances commonly associated with different types of vasculitides. This review also discusses the mechanisms that underlie these manifestations. It also provides a thorough explanation of the many diagnostic techniques essential for detecting the disease at its occult stage. It is essential for healthcare professionals to have knowledge of the cardiovascular complications caused by vasculitides, as this enables them to promptly recognize these symptoms and employ suitable diagnostic techniques early on. By doing so, timely detection can be ensured, which will subsequently aid in initiating appropriate treatment strategies that are vital for decreasing morbidity and mortality in patients with systemic vasculitides.

Keywords: cardiovascular; giant cell arteritis; kawasaki disease; myocardial infarction; myocarditis; takayasu arteritis; vasculitides; vasculitis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Pathophysiology and therapy of systemic vasculitides. Ralli M, Campo F, Angeletti D, et al. EXCLI J. 2020;19:817–854. - PMC - PubMed
    1. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL. Arthritis Rheum. 2005;53:93–99. - PubMed
    1. How to diagnose and treat secondary forms of vasculitis. Luqmani RA, Pathare S, Kwok-Fai TL. Best Pract Res Clin Rheumatol. 2005;19:321–336. - PubMed
    1. Cardiac involvement in systemic and local vasculitides: the value of noninvasive multimodality imaging. Ali AM, Yakupoglu HY, Fuchs TA, Larsen TH, Aukrust P, Gunnarsson R, Saeed S. Curr Probl Cardiol. 2023;48:101718. - PubMed
    1. Vasculitis presenting with myocardial infarction, stroke, and aortitis in a middle-aged man. Wheeler G, Kropf J, Jeanmonod R. J Emerg Med. 2012;43:655–658. - PubMed

LinkOut - more resources